Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Other 2Plasma cell 1

Conditions

Neoplasms 276Breast Neoplasms 266Lung Neoplasms 127Prostatic Neoplasms 124Colorectal Neoplasms 105Carcinoma, Non-Small-Cell Lung 104Pancreatic Neoplasms 70Carcinoma, Hepatocellular 58Stomach Neoplasms 55Hematologic Neoplasms 52Urinary Bladder Neoplasms 50Multiple Myeloma 50Ovarian Neoplasms 49Brain Neoplasms 49Esophageal Neoplasms 46Leukemia, Myeloid, Acute 45Melanoma 44Head and Neck Neoplasms 42Colonic Neoplasms 41Disease 40Neoplasm Metastasis 39Liver Neoplasms 39Rectal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma 32Uterine Cervical Neoplasms 31Endometrial Neoplasms 30Thyroid Neoplasms 29Recurrence 29Leukemia, Lymphocytic, Chronic, B-Cell 29

Interventions

Hematologic Tests 1Echocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Dyspnea × 90 days × Clear all
NCT06866652 2026-05-08

MyaRESP

Institut de Myologie, France

Recruiting
50 enrolled
Other

Dyspnea, Myasthenia Gravis

NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡